Co-Authors
This is a "connection" page, showing publications co-authored by EYAL MUSCAL and YI-CHEN LAI.
Connection Strength
1.860
-
Systemic inflammatory markers and EEG features of children with FIRES receiving anakinra. Ann Clin Transl Neurol. 2023 03; 10(3):440-446.
Score: 0.778
-
New-onset refractory status epilepticus/febrile infection-related epilepsy syndrome centers of excellence: A framework for coordinated care, research, and improved outcomes. Epilepsia. 2026 Jun 08.
Score: 0.246
-
Standard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study. Epilepsia. 2025 Dec; 66(12):4780-4794.
Score: 0.233
-
Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome. Ann Clin Transl Neurol. 2025 04; 12(4):871-875.
Score: 0.224
-
Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann Clin Transl Neurol. 2020 12; 7(12):2467-2474.
Score: 0.168
-
Gastrointestinal symptoms are common in patients with new-onset refractory status epilepticus (NORSE). Neurol Sci. 2025 Oct; 46(10):5305-5314.
Score: 0.058
-
Implementation of an Institutional Protocol for the Use of Intrathecal Dexamethasone for Treatment-Refractory Pediatric Neuroinflammatory Disease. Pediatr Neurol. 2025 Jul; 168:1-5.
Score: 0.057
-
IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report. J Neuroimmunol. 2024 10 15; 395:578430.
Score: 0.054
-
Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop. Epilepsia Open. 2021 03; 6(1):62-72.
Score: 0.042